Feed PODD
PO

Insulet

PODD · NASDAQ

$140.62 +0.86% (+$1.21)
1M -3.31%
Market Cap $9.74B
P/E Ratio 25.95x
Div. Yield -
ROE 26.69%

Bulios Fair Price

$108.36

22.9% downside

Trenutna cena

$140.62

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica PODD trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
9/9
Valuation
39 /100
Fair
P/E 25.95x
EV/EBITDA 15.94x
P/S 3.19x
Growth
100 /100
Growing
EPS growth 275.36%
Rev. growth 27.54%
Book val. growth 47.06%
Profitability
75 /100
Strong
Gross margin 71.08%
Net margin 12.29%
Op. margin 16.89%
Quality
90 /100
Excellent
ROIC 16.04%
ROE 26.69%
ROA 11.86%
Debt
86 /100
Low
Debt/Equity 0.67x
Current ratio 2.48x
Int. coverage 8.80x
Stability
65 /100
Moderate
Beta 1.08x
Rev. volatility 4.81%
EPS volatility 2,506.44%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o PODD
Online

O podjetju

Insulet Corporation (PODD) is an American company specializing in the development and manufacturing of innovative medical devices for diabetes management. Their main product is the Omnipod, which is a wireless insulin pump system. Omnipod is designed to provide simplicity and convenience for patients with type 1 and type 2 diabetes, allowing them to manage their insulin regimen wirelessly. Insulet Corporation also focuses on developing other technologies and products in the field of diabetes management to improve the lives of patients with this condition. Insulet Corporation (PODD) shares may be attractive to investors seeking investments in companies operating in the medical device sector with an emphasis on innovation and improving care for patients with diabetes mellitus.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Ashley McEvoy

Employees

5,400

Headquarters

Acton

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

44d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.